This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Portola Pharmaceuticals, Inc.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Eric L Margelefsky: Innovator in Pharmaceutical Chemistry
Introduction
Eric L Margelefsky is a notable inventor based in Rahway, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. His work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Eric holds a patent for "Crystalline forms of a factor Xa inhibitor." This patent provides crystalline forms of a maleate salt of betrixaban, along with compositions and methods of preparation or use thereof. His innovative approach in this area highlights the importance of developing effective anticoagulant therapies.
Career Highlights
Eric is currently employed at Portola Pharmaceuticals, Inc., where he continues to contribute to the advancement of pharmaceutical research and development. His work at Portola has positioned him as a key player in the industry, focusing on innovative solutions for complex medical challenges.
Collaborations
Eric has collaborated with talented individuals such as Timothy K Maher and Itzia Zoraida Arroyo. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.
Conclusion
Eric L Margelefsky is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His contributions, particularly in the development of factor Xa inhibitors, demonstrate his commitment to improving healthcare outcomes.